Actively Recruiting

Age: 0Years - 100Years
All Genders
NCT06213402

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

Led by Hospital Universitari Vall d'Hebron Research Institute · Updated on 2024-01-19

32564

Participants Needed

1

Research Sites

778 weeks

Total Duration

On this page

Sponsors

H

Hospital Universitari Vall d'Hebron Research Institute

Lead Sponsor

E

Erasme University Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Rare Anaemia Disorders (RADs) is a group of rare diseases characterized for presenting anaemia as the main clinical manifestation. Different medical entities classified as RADs by ORPHA classification are most of them chronic life threating disorders with many unmet needs for their proper clinical management creating an impact on European health systems. RADs present diagnostic challenges and their appropriate management requires from specialised multidisciplinary teams in Centers of expertise. Although there are some examples of well-established national registries on RADs in EU, the lack of recommendations for Rare disease registries implementation and the lack of standards for interoperability has led to the fragmentation or unavailability of data on prevalence, survival, main clinical manifestations or treatments in most of the European countries.

CONDITIONS

Official Title

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

Who Can Participate

Age: 0Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age from 0 to 100 years, female and male
  • Diagnosed with Rare Anaemia Disorders (RADs) including Sickle Cell Disease, Thalassemia, and others classified by ORPHANET
  • Able and willing to provide written informed consent (patient or legal representative for minors)
Not Eligible

You will not qualify if you...

  • Unwilling or unable to provide consent (patient or legal representative for minors)
  • Diagnosed only with sickle cell disease or thalassemia traits or trait conditions for other recessive RADs

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Vall d'hebron Research Institute - Vall d'Hebron Research Institute - University Hospital Vall d'Hebrón (VHIR/HUVH)

Barcelona, Catalonia, Spain, 08035

Actively Recruiting

Loading map...

Research Team

M

María del Mar Manú Pereira, PhD

CONTACT

V

Victoria Gutiérrez Valle, Msc

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here